NASDAQ:BOLT - BioLight Life Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$5.60
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Bolt Technology Corporation consists of four operating units, such as Bolt Technology Corporation (Bolt), A-G Geophysical Products, Inc. (A-G), Real Time Systems Inc. (RTS) and SeaBotix Inc. (SBX). Each of these operating units is reported as a separate reportable segment for all periods presented in the Consolidated Financial Statements. The Company operates in four segments: seismic energy sources reportable segment (Bolt), underwater cables and connectors reportable segment (A-G), seismic energy source controllers reportable segment (RTS) and underwater robotic vehicles segment (SBX). The Company's Bolt, A-G and RTS products are used in marine seismic exploration surveys to acquire seismic data. Bolt develops, manufactures and sells marine seismic energy sources (air guns) and replacement parts. A-G develops, manufactures and sells underwater cables, connectors, hydrophones, depth and pressure transducers and seismic source monitoring systems.

Receive BOLT News and Ratings via Email

Sign-up to receive the latest news and ratings for BOLT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryOil & Gas Equipment & Services
Current SymbolNASDAQ:BOLT



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

BioLight Life Sciences (NASDAQ:BOLT) Frequently Asked Questions

What is BioLight Life Sciences' stock symbol?

BioLight Life Sciences trades on the NASDAQ under the ticker symbol "BOLT."

How were BioLight Life Sciences' earnings last quarter?

BioLight Life Sciences Ltd. (NASDAQ:BOLT) posted its quarterly earnings results on Thursday, October, 23rd. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm earned $11.90 million during the quarter, compared to analyst estimates of $16.20 million. View BioLight Life Sciences' Earnings History.

Has BioLight Life Sciences been receiving favorable news coverage?

Media coverage about BOLT stock has been trending neutral this week, InfoTrie reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. BioLight Life Sciences earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

When did BioLight Life Sciences IPO?

(BOLT) raised $12 million in an initial public offering (IPO) on the week of March 14th 2016. The company issued 2,100,000 shares at a price of $4.60-$6.60 per share. Feltl and Company and Rodman & Renshaw a unit of H.C. Wainwright & Co. served as the underwriters for the IPO.

How do I buy shares of BioLight Life Sciences?

Shares of BOLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

MarketBeat Community Rating for BioLight Life Sciences (NASDAQ BOLT)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  67
MarketBeat's community ratings are surveys of what our community members think about BioLight Life Sciences and other stocks. Vote "Outperform" if you believe BOLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BOLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel